Inspire shareholders seek competing bids and missing data to fight Merck takeover
This article was originally published in Scrip
Executive Summary
Inspire Pharmaceuticals shareholders have asked a North Carolina federal judge to block Merck & Co's $430 million offer for Inspire until investors get additional information on how Merck's "shopping" process was conducted and on possible conflicts in the board's decision to recommend the offer.